In November 2020, a review published in the journal Cardiovascular Diabetology highlighted the renoprotective benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type-2 diabetes patients, over a spectrum of cardiovascular and renal risk profiles.
News / CaReMe Global Alliance
COVID-19 has irrevocably altered the way in which we provide and receive healthcare. In an interview with McKinsey’s David Knott, American venture capitalist Annie Lamont highlights the sudden – and sorely needed – shift from in-hospital care to the remote monitoring.
The annual European Society of Cardiology (ESC) Congress presents the latest scientific insights and innovations to a global audience.
In a recent talk at the CVOT Summit, in October 2020, world-leading US cardiologist Dr Mikhail Kosiborod presented convincing data to support the CaReMe Model of Care.
COVID-19 has irrevocably altered the way in which we provide and receive healthcare. In an interview with McKinsey’s David Knott, American venture capitalist Annie Lamont highlights the sudden – and sorely needed – shift from in-hospital care to the remote monitoring.
Copyright by CaReMe Global Alliance 2022. All rights reserved.
Copyright by CaReMe Global Alliance 2021. All rights reserved.